BIIB — Biogen Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates BIIB Bullish with a Setup Score of 28, net conviction 34, actionability 23. How the Setup Score works →

Total Setup Score28
Directional BiasBullish
Net Conviction34
Actionability23 (in range)

Key signals behind this score

About Biogen Inc

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing … Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$199.15
Market Cap$29.37B
Float147.2M
Shares Outstanding147.6M
P/E (Forward)14.35
P/E (TTM)21.39
Price/Sales (TTM)2.96
vs. Analyst Target+11.9% to analyst PT
Profit Margin13.81%
Operating Margin (TTM)22.90%
Revenue (TTM)$9.94B
Earnings Growth (YoY)31.10%
Dividend RateNone
Analyst Target Price$222.83 (37 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $13.44B $4.00B $11.64B $5.11B
2021 $10.98B $1.56B $8.87B $3.92B
2022 $10.17B $3.05B $7.90B $3.54B
2023 $9.84B $1.16B $7.30B $2.38B
2024 $9.68B $1.63B $7.37B $3.00B
2025 $9.81B $1.29B $6.91B $3.10B

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $2.65B $635M
Sep 2025 $2.45B $467M
Dec 2025 $2.28B -$48.4M
Mar 2026 $2.48B $320M

Ownership & Float

Insider Ownership0.2%
Institutional Ownership96.3%
Short Float3.5%
% of All Funds Holding11.50%
Number of Funds Holding945

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$199.94Near-term / short-term trend
Weekly40-Week SMA$181.87Medium-term trend
Weekly80-Week SMA$158.40Cyclical trend (business cycle)
Weekly200-Week SMA$209.47Secular trend (multi-year)
Monthly10-Month SMA$186.79Near-term monthly trend
Monthly20-Month SMA$160.94Medium-term monthly trend
Monthly40-Month SMA$198.16Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$154.00 support 1.12x 7 months ago
$141.00 support 1.22x 8 months ago
$121.00 support 1.21x 13 months ago

Historical Earnings Reactions (123 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.27% 0.03% 52.03% 38.70% -12.70%
1 Day 0.17% -0.24% 48.78% 26.11% -9.11%
1 Week 0.99% 0.00% 47.97% 38.10% -17.40%
2 Weeks 1.97% 1.49% 56.91% 30.95% -29.55%
1 Month 3.13% 1.51% 60.16% 62.35% -42.51%

Next earnings: July 29, 2026 (16 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan4.0%57.1%35
Feb-0.2%42.9%35
Mar-2.4%45.7%35
Apr-2.0%34.3%35
May3.4%62.9%35
Jun1.9%48.6%35
Jul3.5%67.6%34
Aug3.1%58.8%34
Sep2.3%50.0%34
Oct5.9%54.3%35
Nov1.8%60.0%35
Dec3.4%45.7%35

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.05% 46.1% 1650
Tuesday 0.08% 47.9% 1799
Wednesday 0.31% 49.4% 1796
Thursday 0.03% 47.9% 1763
Friday 0.17% 49.8% 1752

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 96.3%

Insider Transactions — Smart Summary

Total insider ownership: 0.2%

12-Month Insider Activity Summary

Total Filings5
Net Value-$1.7M
Net Shares Change396
% of Float0.0%
C-Suite Filings5
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Singhal Priya Head of Development -$1.4M 3 N/A
Izzar Rachid Head of Global Product Strat. -$300,105 1 N/A
Murphy Nicole Head of Pharm Ops and Tech +$585.105 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-02-17 Murphy Nicole Head of Pharm Ops and Tech +$585.105 Transaction at $195.03, now +2.1%
2026-02-10 Singhal Priya Head of Development -$1.0M Transaction at $200.50, now -0.7%
2025-07-16 Izzar Rachid Head of Global Product Strat. -$300,105 Transaction at $135.00, now +47.5%
2026-02-03 Singhal Priya Head of Development -$238,812.38 Transaction at $179.59, now +10.9%
2025-09-02 Singhal Priya Head of Development -$175,746.89 Transaction at $132.88, now +49.9%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Biogen Inc (BIIB) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for BIIB on Trend Edge →